Wide Ranks

CLVT

Clarivate Plc

5.76

Top Statistics
Market Cap 4 B Forward PE 7.88 Revenue Growth -3.90 %
Current Ratio 0.88 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -50.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 8.57 Enterprise / Revenue 3.28 Price To Sales Trailing12 Months 1.59
Profitability
Profit Margins -50.00 % Operating Margins 11.46 %
Balance Sheet
Total Cash 380 M Total Cash Per Share 0.5360 Total Debt 4 B
Total Debt To Equity 85.89 Current Ratio 0.88 Book Value Per Share 7.76
All Measures
Short Ratio 606.00 % Message Board Id finmb_373723538 Shares Short Prior Month 31 M
Return On Equity -0.2114 City London Uuid 7211f82c-acd5-30fa-b353-0f4031ff54ac
Previous Close 5.58 First Trade Date Epoch Utc 1 B Book Value 7.76
Beta 1.18 Total Debt 4 B Volume 5 M
Price To Book 0.7421 Fifty Two Week Low 4.25 Total Cash Per Share 0.5360
Total Revenue 2 B Shares Short Previous Month Date 1 B Target Median Price 6.00
Max Age 86400 Recommendation Mean 2.40 Sand P52 Week Change 0.3133
Operating Margins 11.46 % Target Mean Price 6.27 Net Income To Common -1339200000
Ask 5.77 Short Percent Of Float 0.0646 Implied Shares Outstanding 710 M
Last Fiscal Year End 1 B Trailing Peg Ratio 25.71 % Average Daily Volume10 Day 8 M
Average Volume10days 8 M Total Cash 380 M Next Fiscal Year End 1 B
Revenue Per Share 3.77 Held Percent Insiders 0.1585 Ebitda Margins 38.25 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 5.58 Target Low Price 4.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 6.12 Open 5.65 Free Cashflow 559 M
Dividend Yield 0.00 % Return On Assets 0.0130 Time Zone Short Name EST
Trailing Eps -1.98 Day Low 5.65 Address1 70 St. Mary Axe
Shares Outstanding 710 M Price Hint 2 Target High Price 8.00
Website https://www.clarivate.com 52 Week Change -0.2577 Average Volume 4 M
Forward Eps 0.7400 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 75.60 % Is_sp_500 False Regular Market Day High 5.81
Profit Margins -50.00 % Debt To Equity 85.89 Fifty Two Week High 9.61
Day High 5.81 Shares Short 35 M Regular Market Open 5.65
Industry Key information-technology-services Bid 5.76 Earnings Growth 0.00 %
Enterprise To Revenue 3.28 Revenue Growth -3.90 % Shares Percent Shares Out 0.0506
Operating Cashflow 696 M Currency USD Time Zone Full Name America/New_York
Market Cap 4 B Is_nasdaq_100 False Zip EC3A 8BE
Quote Type EQUITY Industry Information Technology Services Long Name Clarivate Plc
Regular Market Day Low 5.65 Held Percent Institutions 0.9178 Current Price 5.76
Enterprise To Ebitda 8.57 Financial Currency USD Current Ratio 0.88
Gross Margins 66.12 % Industry Disp Information Technology Services Number Of Analyst Opinions 9
Country United Kingdom Float Shares 400 M Two Hundred Day Average 6.49
Enterprise Value 8 B Price To Sales Trailing12 Months 1.59 Forward PE 7.88
Regular Market Volume 5 M Ebitda 985 M Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific.

It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property.

The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets.

In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement.

It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations.

The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020.

Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.